Hypoxia regulates ABCG2activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells

Cancer statistics, 2014

(2014) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells

(2013) Chunning Zheng et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Advanced pancreatic carcinoma: current treatment and future challenges

(2010) Anastasios Stathis et al.   Nature Reviews Clinical Oncology

Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells

(2010) Young Bin Hong et al.   PANCREAS

Kinases as Upstream Regulators of the HIF System: Their Emerging Potential as Anti-Cancer Drug Targets

(2009) Elitsa Dimova et al.   CURRENT PHARMACEUTICAL DESIGN

HIF-1 regulation: not so easy come, easy go

(2008) Mei Yee Koh et al.   TRENDS IN BIOCHEMICAL SCIENCES

Analysis of mortality rates for pancreatic cancer across the world

(2008) D. Hariharan et al.   HPB